EN
HI
Summary
As of 6 Sep, 2026, Novyra Pharmachem stock price is ₹10.67. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Novyra Pharmachem has traded between ₹5.88 and ₹16.55.
The stock has recorded a trading volume of 0 shares, with a market capitalization of ₹6330000. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹10.67.
Novyra Pharmachem has an upper circuit limit of ₹11.20 and a lower circuit limit of ₹10.14. The total value traded stands at ₹0.00, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 100. Novyra Pharmachem also offers a dividend yield of 0%.
Novyra Pharmachem share price chart
Novyra Pharmachem Share Key Metrics
Volume
0.00
Market Cap
6.75 CR
LTQ@LTP
0@10.67
ATP
0
Var Margin
100 %
Circuit Range
10.14-11.2
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
100
Novyra Pharmachem Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
15.01
Sector P/B
1.28
Sec. Div. Yield
0.3
Novyra Pharmachem Resistance and Support
Pivot 10.67
Resistance
First Resistance
10.67
Second Resistance
10.67
Third Resistance
10.67
Support
First Support
10.67
Second Support
10.67
Third Support
10.67
Novyra Pharmachem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 10.67 | 10.67 | 0.00% | 10.67 | 10.67 |
| Fri Aug 21 2026 | 10.67 | 10.67 | 0.00% | 10.67 | 10.67 |
| Fri Aug 14 2026 | 10.67 | 10.67 | 4.92% | 10.67 | 10.67 |
Novyra Pharmachem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-16 | Reduction of Capital |
| 2026-05-02 | Audited Results |
| 2026-04-29 | Audited Results |
| 2026-04-25 | Audited Results |
| 2026-04-18 | Audited Results |
| 2026-03-20 | Others |
| 2026-01-26 | Quarterly Results |
| 2026-01-22 | Quarterly Results |
| 2025-11-19 | Others |
| 2025-10-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-05-24 | Audited Results |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-07-30 | Quarterly Results |
| 2024-07-25 | Quarterly Results |
Novyra Pharmachem News
Bansisons Tea Industries Ltd - 519353 - Reg 30
Bansisons Tea Industries Ltd has changed its name to Novyra Pharmachem Ltd, reflecting a strategic shift from tea to pharmaceuticals and life sciences. This expansion includes manufacturing APIs, establishing research labs, and offering CRO/CDMO services.
Aug 22 2026 14:03:12
Bansisons Tea Industries Ltd - 519353 - Board Meeting Outcome for Quarterly Results June 30, 2026
Novyra Pharmachem Limited's board approved Q1 FY27 financial results on August 14, 2026. The company reported revenue of ₹172.61 lakhs and a net loss of ₹1.99 lakhs for the quarter ended June 30, 2026.
Aug 14 2026 18:07:37
Read More
Novyra Pharmachem Management
| Name | Position |
|---|---|
| Sandeep Agarwal | Whole Time Director |
| Amit Mitruka | Non Executive Director |
Novyra Pharmachem Similar Stocks
Tarai Foods Ltd.
4.96
0.19 (3.98%)
Omega Ag-Seeds (Punjab) Ltd.
8.65
0.39 (4.72%)
Times Green Energy (India) Ltd.
81.00
0.00 (0.00%)
Shree Hanuman Sugar & Industries Ltd.
4.30
0.02 (0.47%)
SC Agrotech Ltd.
26.32
-0.53 (1.97%)
Retro Green Revolution Ltd.
1.17
-0.03 (2.50%)
Beeyu Overseas Ltd.
2.84
-0.16 (5.33%)
Kanel Industries Ltd.
87.70
2.05 (2.39%)
Novyra Pharmachem FAQs
The Buying Price of Novyra Pharmachem share is 10.67 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novyra Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novyra Pharmachem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novyra Pharmachem shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novyra Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novyra Pharmachem’s valuation compare Sector P/E, P/B which are 15.01 & 1.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novyra Pharmachem is 6.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novyra Pharmachem share price is 16.55 & 5.88. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novyra Pharmachem belongs to the Agriculture sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
